Bausch + Lomb issued the recall after the company received reports of toxic anterior segment syndrome, or an inflammatory ...

Shares of eyecare company Bausch + Lomb (NYSE:BLCO) fell 10.6% in the afternoon session after the company announced the voluntary recall of intraocular lenses on its enVista platform. The recall ...

NEW YORK CITY, NY / ACCESS Newswire / April 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

Bausch + Lomb (NYSE:BLCO) on Thursday announced a voluntary recall of several brands of intraocular lenses marketed under its enVista brand in response to reports of adverse events. Accordingly ...

VAUGHAN, Ontario, March 27, 2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses ...

Bausch + Lomb has recalled its intraocular lenses after receiving reports of cases inflammation. The Canadian eyecare company said Thursday that it has made a voluntary recall of its intraocular ...

Bausch + Lomb has bought US and Canadian rights to a potential biosimilar competitor to Novartis’ Lucentis from Germany’s Stada, as the blockbuster approaches the end of its patent ...

See reviews below to learn more or submit your own review. Bausch & Lomb has manufactured eye health products and vision care solutions since 1853. The company is a global supplier of contact ...